环丙沙星对一家南欧医院分离出的需氧菌的体外活性。
In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.
作者信息
Cornaglia G, Pompei R, Dainelli B, Satta G
机构信息
Istituto di Microbiologia, Università degli Studi di Cagliari, Italy.
出版信息
Antimicrob Agents Chemother. 1987 Oct;31(10):1651-5. doi: 10.1128/AAC.31.10.1651.
Abstract
The activity of ciprofloxacin was evaluated against 1,204 isolates freshly isolated in Southern Europe, including 193 isolates of 10 species never studied before. Ciprofloxacin proved more active than other quinolones and very active in absolute terms against the 10 new species and showed against the other species an activity close to that reported for isolates from other geographic areas.
摘要
对从南欧新分离出的1204株菌株进行了环丙沙星活性评估，其中包括193株属于10个此前从未研究过的物种的菌株。结果表明，环丙沙星比其他喹诺酮类药物活性更强，对这10个新物种具有绝对的高活性，对其他物种的活性与报道的来自其他地理区域的菌株相近。
相似文献
1
In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.环丙沙星对一家南欧医院分离出的需氧菌的体外活性。
Antimicrob Agents Chemother. 1987 Oct;31(10):1651-5. doi: 10.1128/AAC.31.10.1651.
2
Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.环丙沙星对临床分离的需氧菌和厌氧菌的体外活性比较
Arzneimittelforschung. 1987 Jun;37(6):661-6.
3
Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.新型氯氟喹诺酮BAY y 3118与环丙沙星、司帕沙星及其他抗菌药物相比，对厌氧菌的活性增强。
Antimicrob Agents Chemother. 1994 Jul;38(7):1671-4. doi: 10.1128/AAC.38.7.1671.
4
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates.对三种新型喹诺酮类药物（司帕沙星、CI-960和PD 131,628）的体外活性与环丙沙星对5252株临床分离细菌的活性进行多中心评估。
Antimicrob Agents Chemother. 1991 Apr;35(4):764-6. doi: 10.1128/AAC.35.4.764.
5
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.新型氟喹诺酮类药物托氟沙星与环丙沙星和替马沙星的体外活性比较。
J Antimicrob Chemother. 1991 Nov;28(5):719-25. doi: 10.1093/jac/28.5.719.
6
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.新型喹诺酮类药物加替沙星对从普通外科、血管外科、心胸外科和耳鼻喉科手术患者中分离出的需氧和厌氧微生物菌株的体外抗菌活性比较
J Antimicrob Chemother. 2005 Nov;56(5):872-8. doi: 10.1093/jac/dki348. Epub 2005 Sep 26.
7
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
8
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.将曲伐沙星与左氧氟沙星、氧氟沙星、环丙沙星、阿奇霉素和克拉霉素相比较，观察其对人类和动物咬伤伤口中不常见需氧菌和厌氧菌病原体的抗菌活性。
J Antimicrob Chemother. 1998 Mar;41(3):391-6. doi: 10.1093/jac/41.3.391.
9
10
Antibiotic susceptibility of anaerobic bacteria in Europe.欧洲厌氧菌的抗生素敏感性
Clin Infect Dis. 1993 Jun;16 Suppl 4:S387-9. doi: 10.1093/clinids/16.supplement_4.s387.
引用本文的文献
1
Synthesis and Antimicrobial Properties of Highly Cross-Linked pH-Sensitive Hydrogels through Gamma Radiation.通过γ辐射合成高交联pH敏感水凝胶及其抗菌性能
Polymers (Basel). 2021 Jul 6;13(14):2223. doi: 10.3390/polym13142223.
2
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
3
Commercial identification systems often fail to identify Providencia stuartii.商业识别系统常常无法识别斯氏普罗威登斯菌。
J Clin Microbiol. 1988 Feb;26(2):323-7. doi: 10.1128/jcm.26.2.323-327.1988.
4
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
5
Use of a novel phosphatase test for simplified identification of species of the tribe Proteeae.使用一种新型磷酸酶试验简化变形杆菌族菌种的鉴定。
J Clin Microbiol. 1990 Jun;28(6):1214-8. doi: 10.1128/jcm.28.6.1214-1218.1990.
6
Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.环丙沙星治疗肺炎球菌肺炎时的治疗失败及对喹诺酮类药物耐药性的选择
Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):905-6. doi: 10.1007/BF01967510.
7
Modified MacConkey medium which allows simple and reliable identification of Providencia stuartii.改良麦康凯培养基，可实现简单可靠地鉴定斯氏普罗威登斯菌。
J Clin Microbiol. 1992 Aug;30(8):2054-7. doi: 10.1128/jcm.30.8.2054-2057.1992.
本文引用的文献
1
Simplified lyogroup system, a new method for routine identification of staphylococci: description and comparison with three other methods.简化的血清群系统，一种用于葡萄球菌常规鉴定的新方法：描述及与其他三种方法的比较
J Clin Microbiol. 1980 Jul;12(1):63-8. doi: 10.1128/jcm.12.1.63-68.1980.
2
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.新型羧基喹啉抗菌剂环丙沙星的体外活性
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5. doi: 10.1128/AAC.25.3.331.
3
Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.喹诺酮羧酸对变形杆菌属的体外活性比较
J Antimicrob Chemother. 1984 Nov;14(5):485-9. doi: 10.1093/jac/14.5.485.
4
Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae.环丙沙星（BAYo 9867）对铜绿假单胞菌和耐氨苄西林肠杆菌科细菌的活性。
Infection. 1983 Nov-Dec;11(6):326-8. doi: 10.1007/BF01641358.
5
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.环丙沙星、诺氟沙星、恶喹酸、西诺沙星和萘啶酸的抗菌活性。
Antimicrob Agents Chemother. 1984 May;25(5):633-7. doi: 10.1128/AAC.25.5.633.
6
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.环丙沙星，一种对需氧菌和厌氧菌均有活性的喹诺酮羧酸化合物。
Antimicrob Agents Chemother. 1984 Mar;25(3):319-26. doi: 10.1128/AAC.25.3.319.
7
In vitro activity of ciprofloxacin (Bay o 9867).环丙沙星（拜耳o 9867）的体外活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74. doi: 10.1128/AAC.24.4.568.
8
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.环丙沙星、诺氟沙星和萘啶酸的体外活性。
Eur J Clin Microbiol. 1983 Apr;2(2):111-5. doi: 10.1007/BF02001575.
9
Recognition of group D streptococcal species of human origin by biochemical and physiological tests.通过生化和生理学测试识别源自人类的D组链球菌菌种。
Appl Microbiol. 1972 Jun;23(6):1131-9. doi: 10.1128/am.23.6.1131-1139.1972.
10
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.从临床标本中分离出的肠杆菌科新物种和生物群的生化鉴定。
J Clin Microbiol. 1985 Jan;21(1):46-76. doi: 10.1128/jcm.21.1.46-76.1985.
Zotero 插件